EPISODE · Jan 15, 2026 · 17 MIN
SF Healthcare Week: Recursion's new CEO Najat Khan shares her vision for the company and for AI in biotech
from BiotechTV - News · host BiotechTV
Najat Khan describes the impact Recursion's work is having, such the surprising PoC of using MEK1/2 inhibition as a target for treating Familial Adenomatous Polyposis (PAP). Plus, she discusses other programs and large-pharma partnerships, and using new tools such as Boltz-2.
Embed this episode
Ready to play
SF Healthcare Week: Recursion's new CEO Najat Khan shares her vision for the company and for AI in biotech
0:00
17:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of BiotechTV - News?
This episode is 17 minutes long.
When was this BiotechTV - News episode published?
This episode was published on January 15, 2026.
Can I download this BiotechTV - News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!